Article Details

Why Ambrx Biopharma Inc. (NYSE: AMAM) Stock Should Not Be Taken For Granted By ...

Retrieved on: 2023-01-16 13:06:13

Tags for this article:

Click the tags to see associated articles and topics

Why Ambrx Biopharma Inc. (NYSE: AMAM) Stock Should Not Be Taken For Granted By .... View article details on HISWAI: https://marketingsentinel.com/2023/01/16/why-ambrx-biopharma-inc-nyse-amam-stock-should-not-be-taken-for-granted-by-investors-in-2023/

Excerpt

Most recently the company's share price was $2.24, and it changed ... Blackrock Inc., with 7.38% or 2.85 million shares worth $7.56 million as of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up